Editorial: Modeling neuromuscular diseases to determine molecular drivers of pathology and for drug discovery.

Smith, Alec S T; McCain, Megan L; Bothwell, Mark; Mack, David L

Smith, Alec S T; McCain, Megan L; Bothwell, Mark; Mack, David L.

Afiliação

Smith AST; Department of Physiology and Biophysics, University of Washington, Seattle, WA, United States.
McCain ML; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States.
Bothwell M; Department of Biomedical Engineering, USC Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States.
Mack DL; Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

Front Cell Dev Biol ; 10: 1017356, 2022.

Article em En | MEDLINE | ID: mdl-36274836

Palavras-chave

cell line (C2C12); disease modeling; iPSC (induced pluripotent stem cell); in vitro versus in vivo; neuromuscular disease (NMD); therapy screening

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google